Veradigm ROE 2010-2022 | MDRX
Current and historical return on equity (ROE) values for Veradigm (MDRX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Veradigm ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2022-12-31 |
$-0.09B |
$1.02B |
-7.25% |
| 2022-09-30 |
$0.07B |
$1.18B |
5.19% |
| 2022-06-30 |
$0.07B |
$1.20B |
5.03% |
| 2022-03-31 |
$0.15B |
$1.35B |
11.08% |
| 2021-12-31 |
$0.14B |
$1.36B |
9.50% |
| 2021-09-30 |
$0.77B |
$1.42B |
50.02% |
| 2021-06-30 |
$0.76B |
$1.39B |
50.79% |
| 2021-03-31 |
$0.73B |
$1.68B |
50.03% |
| 2020-12-31 |
$0.70B |
$1.67B |
51.95% |
| 2020-09-30 |
$-0.05B |
$1.21B |
-3.70% |
| 2020-06-30 |
$-0.05B |
$1.24B |
-4.20% |
| 2020-03-31 |
$-0.20B |
$1.24B |
-15.22% |
| 2019-12-31 |
$-0.18B |
$1.29B |
-13.71% |
| 2019-09-30 |
$0.21B |
$1.28B |
14.98% |
| 2019-06-30 |
$0.18B |
$1.32B |
13.24% |
| 2019-03-31 |
$0.40B |
$1.46B |
29.92% |
| 2018-12-31 |
$0.36B |
$1.58B |
29.42% |
| 2018-09-30 |
$0.00B |
$1.12B |
-0.44% |
| 2018-06-30 |
$0.00B |
$1.14B |
0.18% |
| 2018-03-31 |
$-0.22B |
$1.11B |
-18.94% |
| 2017-12-31 |
$-0.20B |
$1.16B |
-16.91% |
| 2017-09-30 |
$-0.21B |
$1.15B |
-17.60% |
| 2017-06-30 |
$-0.19B |
$1.17B |
-15.29% |
| 2017-03-31 |
$-0.05B |
$1.19B |
-3.63% |
| 2016-12-31 |
$-0.03B |
$1.27B |
-1.86% |
| 2016-09-30 |
$0.00B |
$1.37B |
-0.14% |
| 2016-06-30 |
$0.00B |
$1.35B |
0.22% |
| 2016-03-31 |
$0.01B |
$1.39B |
0.71% |
| 2015-12-31 |
$0.00B |
$1.42B |
-0.15% |
| 2015-09-30 |
$-0.02B |
$1.40B |
-1.50% |
| 2015-06-30 |
$-0.04B |
$1.39B |
-3.13% |
| 2015-03-31 |
$-0.06B |
$1.28B |
-4.35% |
| 2014-12-31 |
$-0.07B |
$1.28B |
-5.18% |
| 2014-09-30 |
$-0.09B |
$1.28B |
-6.61% |
| 2014-06-30 |
$-0.11B |
$1.30B |
-8.30% |
| 2014-03-31 |
$-0.11B |
$1.31B |
-8.56% |
| 2013-12-31 |
$-0.11B |
$1.32B |
-7.85% |
| 2013-09-30 |
$-0.11B |
$1.33B |
-8.12% |
| 2013-06-30 |
$-0.05B |
$1.37B |
-3.78% |
| 2013-03-31 |
$-0.02B |
$1.33B |
-1.46% |
| 2012-12-31 |
$0.00B |
$1.28B |
-0.07% |
| 2012-09-30 |
$0.05B |
$1.30B |
3.53% |
| 2012-06-30 |
$0.06B |
$1.28B |
4.15% |
| 2012-03-31 |
$0.07B |
$1.49B |
4.61% |
| 2011-12-31 |
$0.07B |
$1.48B |
5.15% |
| 2011-09-30 |
$0.04B |
$1.44B |
2.97% |
| 2011-06-30 |
$0.02B |
$1.41B |
1.72% |
| 2011-03-31 |
$0.02B |
$1.43B |
2.01% |
| 2010-09-30 |
$0.03B |
$1.37B |
6.07% |
| 2010-06-30 |
$0.05B |
|
12.55% |
| 2010-03-31 |
$0.05B |
|
9.13% |
| 2010-02-28 |
$0.05B |
$0.79B |
8.10% |
| 2009-09-30 |
$0.04B |
|
7.23% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.455B |
$0.588B |
|
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO.
|
